BioSpace News Archive

Genome editing tools have come a long way from the mid-twentieth century. In 1970s and 1980s, gene targeting was done using largely homologous combination, but was only possible in mice.

The global ELISA readers and washers market is prognosticated to witness a promising growth in the coming years owing to the cost efficiency and higher productivity that it offers as compared to other readers.

InnoCare Pharma and Keymed Biosciences jointly announced that the first patient in China has been dosed in clinical trial of CM355, a CD20xCD3 bispecific antibody developed by a joint venture between the two companies, for the treatment of CD20+ B-cell malignancies.

Alligator Bioscience announced an update on the on-going OPTIMIZE-1 clinical Phase Ib/II trial with the company’s lead asset, mitazalimab.

NuGen Medical Devices Inc. is pleased to announce that it has entered into an exclusive distribution agreement with Intermediq Holdings Ltd., a well-established medical distribution company in Sri Lanka.

Immuneering Corporation today announced the appointment of Diana F. Hausman, M.D., Chief Medical Officer of Lengo Therapeutics (a wholly-owned subsidiary of Blueprint Medicines Corporation), to its Board of Directors.

China SXT Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of its ordinary shares and prefunded warrants to purchase ordinary shares, with gross proceeds to the Company expected to be approximately $3.5 million, before deducting underwriting discounts and commissions and other estimated expenses payable by the Company.

GRO Biosciences Inc. today announced the appointment of Rakhshita Dhar to its Board of Directors.

Leyden Laboratories B.V., announces the development of an intranasal spray protecting against influenza A and influenza B based on the human monoclonal antibody CR9114.

BioInvent International AB, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, announces the appointment of Marie Moores as Chief Operating Officer.